(Q84525251)

English

Antiangiogenic agents for the treatment of nonsmall cell lung cancer: characterizing the molecular basis for serious adverse events

scientific article published on 01 August 2011

In more languages

default values for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21740083

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21740083%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 February 2020

title

Antiangiogenic agents for the treatment of nonsmall cell lung cancer: characterizing the molecular basis for serious adverse events (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21740083

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21740083%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 February 2020

main subject

angiogenesis inhibitor

1 reference

Shenhong Wu

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21740083

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21740083%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 February 2020

Roger S Keresztes

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21740083

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21740083%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 February 2020

publication date

1 August 2011

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21740083

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21740083%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

21740083

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21740083%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 February 2020

volume

29

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21740083

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21740083%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 February 2020

issue

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21740083

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21740083%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 February 2020

page(s)

460-471

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21740083

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21740083%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 February 2020

Identifiers

PubMed publication ID

21740083

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21740083

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21740083%20AND%20SRC:MED&resulttype=core&format=json

(Q84525251)

Antiangiogenic agents for the treatment of nonsmall cell lung cancer: characterizing the molecular basis for serious adverse events

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)